Replies to post #224265 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

We hold the patents on some of this, don't we?

There's no reason why we can't share research and still charge them to use it :-).

So question, why do we need to open up our science and PM trial design to this group...especially sitting at a suppressed 150 million market cap, for free?

[TempePhil]

Treden et al. Regarding the consortium...Yes, we have done some of these, like sometimes ERP, now adding gut tests, etc. The purpose is exactly as was quoted... To come up with standardized, validated psycometric testing procedures, that are accepted industry wide.
When the procedures are written up, every CRO can simply specify testing per the published procedure. It helps the industry not having to invent the wheel for various, future STANDARDIZED PROCEDURES.

I have been in these consortiums. No company provides any more info than is needed to reach the goal (standards). Companies are very careful about what they reveal. Frequently members of a consortium are competitors!

Dont think that this is a grand partnership. It is NOT. Now it does give companies a chance to rub elbows and dinners with other industry leaders, and something could come from that, but dont expect anything like that.

[georgejjl]

Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects

https://clinicaltrials.gov/ct2/show/NCT04025502

Sponsors and Collaborators
ERP Biomarker Qualification Consortium
COGNISION
Cadent Therapeutics
Alkermes, Inc.
Anavex Life Sciences Corp.
Merck Sharp & Dohme Corp.
Takeda
Sage Therapeutics
H. Lundbeck A/S
Investigators
Principal Investigator: Marco Cecchi, PhD

ERP Biomarker Qualification Consortium


Good luck and GOD bless,